ProSomnus Secures $38 Million Strategic Investment from Catalio Capital Management to Scale Smart Sleep Medicine™
Strategic alliance focuses on scaling data-integrated sleep solutions to meet surging clinical and consumer demand SAN FRANCISCO–(BUSINESS WIRE)–ProSomnus Sleep Technologies (“the Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy® and pioneer in Smart Sleep Medicine™,…